Evonik Venture Capital
Evonik Venture Capital (EVC) is the corporate venture capital unit of German specialty chemicals group Evonik Industries, investing off the parent balance sheet since 2012. From offices in Germany, the USA and China it takes minority stakes of up to 15 million euros in start-ups across advanced and sustainable materials, health and precision biosolutions, the energy transition and enabling digital technologies, and it has made about 55 direct and fund investments. It also commits selectively to third-party venture funds as a limited partner and runs a dedicated Sustainability Tech Fund launched in 2022.
Key facts
Recent exits
Coverage notes
1 fund tracked, 29 portfolio companies (20 active · 9 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
29 companiesFunds & portfolio
Every fund Evonik Venture Capital has raised, with its portfolio companies. Hand-checked from public filings.
Evonik Venture CapitalVCActive2012 · 14yr20 active · 9 realized
Unrealized
20 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech |  France | 2024 | |
| MedTech |  US | 2022 | |
| MedTech |  Denmark | 2022 | |
| Software | Israel | 2019 | |
| MedTech | US | 2022 | |
| AI/ML | US | 2022 | |
| ClimateTech | Denmark | 2017 | |
| AgTech |  Netherlands | 2018 | |
| Industrials |  UK | 2023 | |
| Biotech | China | 2024 | |
| Pharma | US | 2022 | |
| Biotech | US | 2019 | |
| Industrials | US | 2017 | |
| Biotech |  Germany | 2017 | |
| Biotech | Singapore | 2021 | |
| AgTech | China | 2020 | |
| Energy | Netherlands | 2019 | |
| ClimateTech | China | 2023 | |
| Industrials | China | 2020 | |
| Industrials | Israel | 2018 |
France· Entry 2024US· Entry 2022Denmark· Entry 2022US· Entry 2022US· Entry 2022Denmark· Entry 2017Netherlands· Entry 2018UK· Entry 2023US· Entry 2022US· Entry 2019US· Entry 2017Germany· Entry 2017Netherlands· Entry 2019Realized
9 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | US | 2014 | 2017 | Trade Sale | – | ||
| Industrials | US | 2014 | 2018 | Trade Sale | – | ||
| Software |  Switzerland | 2019 | 2021 | Trade Sale | – | ||
| Industrials | US | 2013 | 2022 | IPO | – | – | |
| Biotech | Germany | 2015 | 2021 | Trade Sale | – | ||
| Deep Tech |  Finland | 2015 | 2023 | Trade Sale | – | ||
| Industrials | US | 2017 | 2019 | Trade Sale | – | ||
| MedTech | Finland | 2015 | 2020 | Trade Sale | – | ||
| MedTech |  Ireland | 2016 | 2026 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Evonik Venture Capital
Evonik Venture Capital is the corporate venture capital arm of Evonik Industries with €400 million of fund volume as of December 2024, headquartered in Essen, Germany with offices in the USA and China. The firm was founded in 2012 as the corporate venture capital arm of the Evonik Industries specialty chemicals group and operates as a wholly-owned subsidiary with 50 plus direct and fund investments since 2012.
Investment thesis
Evonik Venture Capital deploys capital through a single €400 million evergreen-style corporate vehicle, targeting early-stage to growth-stage direct equity plus fund-of-funds commitments with up to €15 million per portfolio company. The strategy invests to give a global specialty-chemicals corporate early access to sustainability and decarbonisation technologies adjacent to its core business. Sector focus spans advanced precision biosolutions, energy transition, circular economy, smart and new materials, nutrition and care and specialty additives. Geographic deployment spans Germany, USA and China with European and North American deal focus.
Recent activity
Recent realised exits include materials and biotech (2023, most recent on record). Recent acquisitions include CircumFix (medtech Series A, 2024) plus two new portfolio investments completed in 2024. The platform continues active deployment across the strategic specialty-chemicals venture thesis. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
Germany·€20.0B
Germany·€3.0B
Germany·€2.8B
Germany·€2.5B
Germany·€2.3B
Germany·€1.9B
Germany·€1.8B
Germany·€1.8B
Germany·€1.5B
Germany·€1.5B
Germany·€1.4B
Germany·€1.4BGet the full picture on Evonik Venture Capital.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in